SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Babcock & Wilcox Enterprises, I (BWSN) , forward earnings yield 0.45%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 224.2
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BWSN
Valuation Multiples
P/E (TTM)0.0
Forward P/E224.2
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.52
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.48
Forward EPS (Est.)$0.11
Book Value / Share$0.00
Revenue / Share$5.58
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield0.45%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-11.50 |
$1.58B |
$-115.6M |
-7.3% |
| 2017 |
$-40.34 |
$1.56B |
$-379.82M |
-24.4% |
| 2018 |
$-52.45 |
$1.06B |
$-725.29M |
-68.3% |
| 2019 |
$-4.12 |
$859.1M |
$-129.7M |
-15.1% |
| 2020 |
$-0.25 |
$566.3M |
$-12.1M |
-2.1% |
| 2021 |
$0.26 |
$723.4M |
$30.89M |
4.3% |
| 2022 |
$-0.30 |
$889.8M |
$-26.6M |
-3% |
| 2023 |
$-2.38 |
$999.35M |
$-197.21M |
-19.7% |
| 2024 |
$-0.82 |
$717.33M |
$-59.92M |
-8.4% |
| 2025 |
$-0.48 |
$587.7M |
$-36.1M |
-6.1% |